Popular Pre-Market Trades in U.S. Stocks
Venus Concept, down 4.42% in pre-market trading, has no significant news recently. Trading is active with clear capital flows. Considering sector and industry trends, the stock shows significant volatility, and specific reasons need further observation.
Bloom Energy is up 4.21% in pre-market trading. Based on recent key news:
<ol>
<li>
On December 16, Bloom Energy signed a $5 billion cooperation agreement with Brookfield Asset Management to promote hydrogen fuel cell technology applications, boosting market confidence and driving the stock price up.
</li>
<li>
On December 15, BTIG analyst Gregory Lewis reiterated a buy rating on Bloom Energy with a target price of $145, enhancing investor confidence and pushing the stock price higher.
</li>
<li>
On December 17, a Benzinga report indicated unusual options activity for Bloom Energy, with the market optimistic about its future performance, further stimulating the stock price increase. The resonance of hydrogen energy policies presents an optimistic industry outlook.
</li>
</ol>
Top Gainers in Pre-Market U.S. Stocks
Agape ATP is up 60.67% in pre-market trading. Based on recent news:
<ol>
<li>
On December 17, Agape ATP announced its commitment to diversifying its business, covering health and wellness as well as sustainable green energy sectors, to provide sustainable equity performance value for investors. This news boosted market confidence and drove the stock price up.
</li>
<li>
Recent financial reports show that Agape ATP's third-quarter revenue fell from $465,500 in the second quarter to $370,590, with a per-share loss maintained at $0.01. Despite poor financial performance, the company's future development plans attracted investor attention.
</li>
<li>
Benzinga's stock rankings indicate that ATPC shares have shown a negative price trend across all time frames. However, recent diversification plans may change this trend. Market interest in health and green energy sectors is increasing.
</li>
</ol>
Aditxt is up 49.30% in pre-market trading. Based on recent news:
<ol>
<li>
On December 15, Aditxt announced a $20 million financing, leading to a drop in stock price. Investors expressed concerns about further dilution of shares, putting pressure on the stock price.
</li>
<li>
As of December 17, Aditxt's stock price has fallen 99.97% year-to-date, with a market capitalization of only $794,410. Nevertheless, the pre-market stock price surged significantly, indicating some market optimism about its future development.
</li>
<li>
On December 17, Benzinga Pro data showed that Aditxt's stock price closed down 1.39% on Tuesday, at $1.42. Despite recent poor performance, pre-market trading volume surged, driving the stock price up significantly. The biotechnology sector has been volatile recently, and investors should exercise caution
Direct Digital, pre-market up 43.48%, with no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation
</li>
</ol>

VERO

Venus Concept pre-market down 4.42%; Bloom Energy pre-market up 4.21%; Agape ATP pre-market up 60.67%; Aditxt pre-market up 49.30%; Direct Digital pre-market up 43.48%

Pre-market hot trades in US stocks: Venus Concept down 4.42% in pre-market; Bloom Energy up 4.21% in pre-market